Published Healthcare & Pharmaceuticals Multiple Myeloma Prognostics A flow cytometry based test that rapidly identifies patients with MM from their bone marrow and better predicts disease progression at time of diagnosis. By UniSA Ventures
Published Healthcare & Pharmaceuticals Treatment for Multiple Myeloma This technology is a SR-18465 compound, which is an osteoclastogenesis matrix metalloproteinase 13 (MMP-13) highly specific inhibitor for the treatment of multiple myeloma. By Florida Atlantic University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
